COMPARING EFFICACY OF TWO DIFFERENT HORMONAL THERAPY REGIMEN ON ACTIVITY OF COAGULATION FACTORS VII, VIII, IX AND SERUM LIPIDS IN MENOPAUSED WOMEN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ASGARI SEDIGHEH; SADEGHI M.; NADERI GH.A.; ASGARI N.; POURSHAMS A.; ZOU ALFAGHARI S.; FAZELI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Diabetes and Metabolism Year:2004 | Volume:4 | Issue:1 Page(s): 85-90

Download Full-Text

Persian Verion

View:

1,115

Download:

Cites:

Information Journal Paper

Title

COMPARING EFFICACY OF TWO DIFFERENT HORMONAL THERAPY REGIMEN ON ACTIVITY OF COAGULATION FACTORS VII, VIII, IX AND SERUM LIPIDS IN MENOPAUSED WOMEN

Author(s)

Keywords

BLOOD COAGULATION FACTORSQ4

HORMONE THERAPYQ3

FACTOR VIIQ4

FACTOR VIIIQ4

FACTOR IXQ4

SERUM FIBRINOGENQ4

Abstract

Background: During extrinsic coagulation pathway, a complex is developed between FACTOR VII, calcium and tissue factor (a cell membrane lipoprotein that is exposed after cell injury). FACTOR VII needs calcium and vitamin K for its biologic activation. Coronary artery disease can be induced by increased level and activity of the coagulation factors VII, VIII and IX. In postmenopausal period, estrogen can decrease blood lipids and thereby decreases risk of coronary artery disease. However, the exact effects of the estrogen on the other predisposing factors of the coronary artery diseases are unknown. Our objective in this study was to evaluate the effects of oral HORMONE THERAPY regimen on fibrinogen and other coagulation factors. Methods: 60 menopause women with history of hysterectomy were randomly allocated in 2 groups. One group was treated with conjugated estrogen 0.625mg/day and the other group was treated with conjugated estrogen 0.625mg/day and medroxy progesterone 2.5mg/day. SERUM FIBRINOGEN level and activity of coagulation factors VII, VIII and IX and blood lipids level were checked before and 3 months after treatment. Results: In the estrogen alone treated group, mean of FACTOR VII activity showed significant elevation 3 months after treatment as compared with prior to HORMONE THERAPY (p<0.05). There were no significant changes in means of coagulation factors VIII, IX activities and SERUM FIBRINOGEN level in estrogen ± medroxy progesterone treated patients before and after treatment (p>0.05). In both groups, honi1one therapy significantly decreased serum cholesterol level and LDL-C and increased HDL-C (p>0.00) but the serum triglyceride level was increased in the estrogen alone treated group. Conclusion: Significant elevation of coagulation factors VII with significant elevation of serum triglyceride in estrogen treated patients is explainable. This study confirms that HORMONE THERAPY with this protocol does not change SERUM FIBRINOGEN mean and activity of coagulation FACTOR VIII and IX. This finding may be real or may be related to inadequacy of samples regarding the wide normal range of coagulation factors and SERUM FIBRINOGEN. Studies with more prolonged follow-up or more samples are suggested.

Cites

No record.

References

No record.

Cite

APA: Copy

ASGARI, SEDIGHEH, SADEGHI, M., NADERI, GH.A., ASGARI, N., POURSHAMS, A., ZOU ALFAGHARI, S., & FAZELI, M.. (2004). COMPARING EFFICACY OF TWO DIFFERENT HORMONAL THERAPY REGIMEN ON ACTIVITY OF COAGULATION FACTORS VII, VIII, IX AND SERUM LIPIDS IN MENOPAUSED WOMEN. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 4(1), 85-90. SID. https://sid.ir/paper/53961/en

Vancouver: Copy

ASGARI SEDIGHEH, SADEGHI M., NADERI GH.A., ASGARI N., POURSHAMS A., ZOU ALFAGHARI S., FAZELI M.. COMPARING EFFICACY OF TWO DIFFERENT HORMONAL THERAPY REGIMEN ON ACTIVITY OF COAGULATION FACTORS VII, VIII, IX AND SERUM LIPIDS IN MENOPAUSED WOMEN. JOURNAL OF DIABETES AND METABOLIC DISORDERS[Internet]. 2004;4(1):85-90. Available from: https://sid.ir/paper/53961/en

IEEE: Copy

SEDIGHEH ASGARI, M. SADEGHI, GH.A. NADERI, N. ASGARI, A. POURSHAMS, S. ZOU ALFAGHARI, and M. FAZELI, “COMPARING EFFICACY OF TWO DIFFERENT HORMONAL THERAPY REGIMEN ON ACTIVITY OF COAGULATION FACTORS VII, VIII, IX AND SERUM LIPIDS IN MENOPAUSED WOMEN,” JOURNAL OF DIABETES AND METABOLIC DISORDERS, vol. 4, no. 1, pp. 85–90, 2004, [Online]. Available: https://sid.ir/paper/53961/en

Related Journal Papers